Back
Editas Medicine Stock Price Chart
Sponsored
EDIT
Sponsored
The Mysterious VC Firm Behind Nvidia's Secret Weapon
Details Here!
Buy
54
EDIT
Editas Medicine
Last Price:
3.12
Seasonality Move:
16.26%
7 Day Trial
ALL ACCESS PASS
$
7
U.S. Government Report Alert Tuesday
Discover the Secret Loophole- Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and EDIT is experiencing slight selling pressure.
Editas Medicine Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 3.05 | Buy |
20-day SMA: | 3.2 | Sell |
50-day SMA: | 3.4 | Sell |
200-day SMA: | 5.44 | Sell |
8-day EMA: | 3.12 | Buy |
20-day EMA: | 3.18 | Sell |
50-day EMA: | 3.47 | Sell |
200-day EMA: | 5.22 | Sell |
Editas Medicine Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.1 | Sell |
Relative Strength Index (14 RSI): | 46.22 | Sell |
Chaikin Money Flow: | -650602 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (3 - 3.38) | Sell |
Bollinger Bands (100): | (3.24 - 4.92) | Sell |
Editas Medicine Technical Analysis
Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | |
---|---|---|---|---|---|---|---|---|---|---|
Oct | Nov | |||||||||
28 | 29 | 30 | 31 | 01 | 04 | 05 | 06 | 07 | 08 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Editas Medicine Stock
Is Editas Medicine Stock a Buy?
- Editas Medicine share price is 3.12 while EDIT 8-day simple moving average is 3.05, which is a Buy signal.
- The stock price of EDIT is 3.12 while Editas Medicine 20-day SMA is 3.20, which makes it a Sell.
- Editas Medicine 50-day simple moving average is 3.40 while EDIT share price is 3.12, making it a Sell technically.
- EDIT stock price is 3.12 and Editas Medicine 200-day simple moving average is 5.44, creating a Sell signal.
EDIT Technical Analysis vs Fundamental Analysis
Buy
54
Editas Medicine (EDIT)
is a Buy
Is Editas Medicine a Buy or a Sell?
-
Editas Medicine stock is rated a Buy
The current Editas Medicine [EDIT] share price is $3.12. The Score for EDIT is 54, which is 8% above its historic median score of 50, and infers lower risk than normal.
Editas Medicine Stock Info
Market Cap:
257.55M
Price in USD:
3.12
Share Volume:
1.65M
Editas Medicine 52-Week Range
52-Week High:
11.69
52-Week Low:
2.70
Buy
54
Editas Medicine (EDIT)
is a Buy
Editas Medicine Share Price Forecast
-
What is the Editas Medicine stock price today?
The Editas Medicine stock price is 3.12 USD today. -
Will EDIT stock go up or go down?
Editas Medicine> share price is forecast to RISE/FALL based on technical indicators -
Is Editas Medicine overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Editas Medicine is not overvalued.
Is Editas Medicine Stock a Buy?
- Editas Medicine share price is 3.12 while EDIT 8-day exponential moving average is 3.12, which is a Buy signal.
- The stock price of EDIT is 3.12 while Editas Medicine 20-day EMA is 3.18, which makes it a Sell.
- Editas Medicine 50-day exponential moving average is 3.47 while EDIT share price is 3.12, making it a Sell technically.
- EDIT stock price is 3.12 and Editas Medicine 200-day simple moving average is 5.22, creating a Sell signal.
Fundamental Analysis of Editas Medicine
Is Editas Medicine a good investment?
- Analysts estimate an earnings decrease this quarter of $0.09 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.42 per share, and an increase next year of $0.23 per share.
Technical Analysis of Editas Medicine
Should I short Editas Medicine stock?
- EDIT Moving Average Covergence Divergence (MACD) indicator is -0.1, suggesting Editas Medicine is a Sell
- Editas Medicine Relative Strength Index (RSI) is 46.22, which suggest Editas Medicine is oversold
- The Bollinger Bands (25) for Editas Medicine is (3 - 3.38), which suggest Editas Medicine is a Sell
- The Bollinger Bands (100) for Editas Medicine is (3.24 - 4.92), which suggest Editas Medicine is a Sell
* Editas Medicine stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.